---
layout: post
title: "【图解季报】华恒生物：2022年一季度归母净利润同比大增77.7%，约为5523万元"
date: 2022-04-29 18:03:39 +0800
categories: dongfangcaifuChoiceshuju
tags: 东方财富Choice数据新闻
---
<p>华恒生物于2022年4月30日披露一季报，公司2022年一季度实现营业总收入2.7亿元，同比增长63.8%；实现归母净利润5523万元，同比增长77.7%；每股收益为0.51元。</p><img id="image7" class="autoimg" src="https://dfscdn.dfcfw.com/download/D21883352E3DD612CC92B192ECB8682556_w800h400.jpg" alt=""><p style="color:#61768C;font-size:0.9em;"></p><img id="image9" class="autoimg" src="https://dfscdn.dfcfw.com/download/D2480A1EA9547FD7A44C1CA201507086AD_w800h400.jpg" alt=""><p><strong>期间费用率升高4.9%，经营性现金流由负转正（本期金额为6830万元）</strong></p><p>公司2022一季度营业成本1.65亿元，同比增长47.6%，低于营业收入63.8%的增速，导致毛利率上升6.7%。期间费用率为16.1%，较上年升高4.9%。经营性现金流由-623万元增加至6830万元，同比上升1197.1%。</p><img id="image12" class="autoimg" src="https://dfscdn.dfcfw.com/download/D28F975A8E1676EFC75B8076002C3D158F_w800h400.jpg" alt=""><p style="font-weight:bold;"></p><p style="margin: 10px 0; color: #999">免责声明：本文基于大数据生产，仅供参考，不构成任何投资建议，据此操作风险自担。</p><style>.autoimg {display: block;border: 0;max-width: 100%;margin: 0 auto;} .tbl {border-collapse: collapse;border-spacing: 0;text-align: center;width: 100% !important;} .tbl tr th, .tbl tr td {border: 1px solid #d8e6ff;padding: 5px;text-align: center;} .tbl tr th {color: #fff;background-color: #1c65b0;vertical-align: middle;} .tbl tr td {color: #000;background-color: #fff;} .imgtitle {text-indent: 0;text-align: center;color: #2395F1;} .autosrc {color: #999;display: block;text-align: center;margin-bottom: 5px;}</style>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202204292366595021>

[返回东方财富Choice数据新闻](//finews.withounder.com/category/dongfangcaifuChoiceshuju.html)｜[返回首页](//finews.withounder.com/)